dr oz semaglutide Dr. Mehmet Oz, administrator of Medicare and Medicaid Services, joins NewsNation to discuss the Trump administration’s decision to slash prices on weight loss drugs like Wegovy and Ozempic GLP-1 Weight Loss Medication Guide:

This can lead to guilt, frustration, and ultimately giving up on the weight loss plan altogether

Tirzepatide was generally well tolerated, with GI issues such as decreased appetite, nausea, and diarrhea being the most common adverse events

It may be used off-label by qualified medical providers as an investigational therapy, and availability through compounding pharmacies is subject to evolving regulatory guidance

Understanding your biomarker baseline and genetic predispositions empowers you to have a more informed conversation with your provider about fatigue risk mitigation before it becomes problematic

In my practice as a bariatric surgeon, I've seen firsthand the advantages of GLP-1 agonists, but I've also noticed a pattern of misuse and misunderstanding regarding their role, particularly in the treatment of morbid obesity